Clinical trial
First in Man Safety Evaluation of the ART18Z Bioresorbable Stent for the Treatment of Single de Novo Lesion of a Native Coronary Artery.
NCT01761578 is registered in ClinicalTrials.gov with Arterial Remodeling Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- First in Man Safety Evaluation of the ART18Z Bioresorbable Stent for the Treatment of Single de Novo Lesion of a Native Coronary Artery.
- Lead sponsor
- Arterial Remodeling Technologies
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2012
- Completion date
- Not reported
- Enrollment
- 30 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.